Besser GM - Search Results

1

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.

Bomanji J, Britton KE, Ur E, Hawkins L, Grossman AB, Besser GM. Bomanji J, et al. Among authors: besser gm. Nucl Med Commun. 1993 Oct;14(10):856-61. doi: 10.1097/00006231-199310000-00004. Nucl Med Commun. 1993. PMID: 8233228

2

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.

Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, Drake WM, Plowman PN, Besser GM, Chew SL, Grossman AB, Monson JP, Britton KE. Ali N, et al. Among authors: besser gm. Nucl Med Commun. 2006 Feb;27(2):165-9. doi: 10.1097/01.mnm.0000194397.20067.b6. Nucl Med Commun. 2006. PMID: 16404230 Clinical Trial.

3

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.

Bomanji J, Mather S, Moyes J, Ellison D, Grossman A, Britton KE, Besser GM. Bomanji J, et al. Among authors: besser gm. J Nucl Med. 1992 Jun;33(6):1121-4. J Nucl Med. 1992. PMID: 1597726 Free article.

4

Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas.

Sinclair AJ, Bomanji J, Harris P, Ross G, Besser GM, Britton KE. Sinclair AJ, et al. Among authors: besser gm. Nucl Med Commun. 1989 Aug;10(8):567-76. doi: 10.1097/00006231-198908010-00005. Nucl Med Commun. 1989. PMID: 2812639

5

Imaging of phaeochromocytoma and adrenal medulla with 123I-meta-iodobenzyl guanidine.

Horne T, Hawkins LA, Britton KE, Granowska M, Bouloux P, Besser GM. Horne T, et al. Among authors: besser gm. Nucl Med Commun. 1984 Dec;5(12):763-8. doi: 10.1097/00006231-198412000-00004. Nucl Med Commun. 1984. PMID: 6533496

6

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.

Kaltsas GA, Putignano P, Mukherjee JJ, Satta MA, Lowe DG, Britton KE, Monson JP, Grossman AB, Besser GM. Kaltsas GA, et al. Among authors: besser gm. Clin Endocrinol (Oxf). 1998 Nov;49(5):685-9. doi: 10.1046/j.1365-2265.1998.00527.x. Clin Endocrinol (Oxf). 1998. PMID: 10197087 Review.

7

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

Mukherjee JJ, Kaltsas GA, Islam N, Plowman PN, Foley R, Hikmat J, Britton KE, Jenkins PJ, Chew SL, Monson JP, Besser GM, Grossman AB. Mukherjee JJ, et al. Among authors: besser gm. Clin Endocrinol (Oxf). 2001 Jul;55(1):47-60. doi: 10.1046/j.1365-2265.2001.01309.x. Clin Endocrinol (Oxf). 2001. PMID: 11453952

8

The diagnosis and medical management of advanced neuroendocrine tumors.

Kaltsas GA, Besser GM, Grossman AB. Kaltsas GA, et al. Among authors: besser gm. Endocr Rev. 2004 Jun;25(3):458-511. doi: 10.1210/er.2003-0014. Endocr Rev. 2004. PMID: 15180952 Review.

9

Pituitary imaging using a labelled somatostatin analogue in acromegaly.

Ur E, Mather SJ, Bomanji J, Ellison D, Britton KE, Grossman AB, Wass JA, Besser GM. Ur E, et al. Among authors: besser gm. Clin Endocrinol (Oxf). 1992 Feb;36(2):147-50. doi: 10.1111/j.1365-2265.1992.tb00949.x. Clin Endocrinol (Oxf). 1992. PMID: 1348978

10

Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.

Bomanji J, Levison DA, Flatman WD, Horne T, Bouloux PM, Ross G, Britton KE, Besser GM. Bomanji J, et al. Among authors: besser gm. J Nucl Med. 1987 Jun;28(6):973-8. J Nucl Med. 1987. PMID: 3585505 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

588 results

Search Page